AC-101 for colitis, ulcerative

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Aug 2026: Trial registered, NCT07755241
  2. 10 Sep 2026: Trial started, NCT07755241

The trials

NCT07755241: A Study of AC-101 Tablets in Patients With Ulcerative Colitis

State
Under way
Phase
Phase 2
People
153 planned
Started
10 Sep 2026
Primary completion
30 Nov 2027
Arms
AC-101 cohort 1, AC-101 cohort 2
Results
None posted
  1. 10 Aug 2026: Trial registered
  2. 10 Sep 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.